Antimicrobial Agents Practice Questions

Q: Maraviroc acts as which of the following?

Entry inhibitor. **Explanation:** **Maraviroc** is a specialized antiretroviral drug classified as an **Entry Inhibitor**. Its specific mechanism involves binding to the **CCR5 receptor** on the surface of human CD4+ T-cells. By acting as a **CCR5 coreceptor antagonist**, it prevents the HIV-1 gp120 protein from interacting with the host cell, thereby blocking the virus from entering the cell. **Analysis of Options:** * **Option A (Reverse Transcriptase Inhibitors):** These drugs (e.g., Zidovudine, Efavirenz) act intracellularly to prevent the conversion of viral RNA into DNA. Maraviroc acts extracellularly before the virus enters. * **Option B (Protease Inhibitors):** These drugs (e.g., Ritonavir, Atazanavir) act at the final stage of the viral life cycle by preventing the cleavage of precursor polypeptides, thus stopping the maturation of new virions. * **Option C (Correct):** Maraviroc prevents the initial "docking" and entry phase of the HIV life cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Tropism Requirement:** Maraviroc is only effective against **R5-tropic HIV** (viruses that use the CCR5 receptor). It is ineffective against X4-tropic (CXCR4) or dual-tropic viruses. A **Trofile assay** must be performed before starting treatment. * **Metabolism:** It is a substrate of **CYP3A4**; therefore, dosage adjustments are required when co-administered with CYP3A4 inhibitors (like Ritonavir) or inducers (like Rifampin). * **Difference from Enfuvirtide:** While both are entry inhibitors, **Enfuvirtide** is a fusion inhibitor that binds to the viral **gp41** subunit, whereas Maraviroc binds to the host **CCR5** receptor.

Q: Voriconazole is not effective against which of the following?

Mucormycosis. **Explanation:** The correct answer is **Mucormycosis**. Voriconazole is a second-generation triazole and a derivative of fluconazole. While it has an expanded spectrum compared to its predecessor, it has a significant clinical "gap": it lacks activity against the **Mucorales** order (the causative agents of Mucormycosis). **1. Why Mucormycosis is the correct answer:** Voriconazole is ineffective against Zygomycetes (Mucor and Rhizopus species). In fact, prolonged use of voriconazole in immunocompromised patients is a known risk factor for the development of breakthrough Mucormycosis. The drugs of choice for Mucormycosis are **Amphotericin B** (Liposomal) or newer azoles like **Isavuconazole** and **Posaconazole**. **2. Why other options are incorrect:** * **Aspergillosis:** Voriconazole is the **drug of choice (DOC)** for invasive Aspergillosis, offering better survival rates and fewer side effects than Amphotericin B. * **Candida species (C. albicans & C. tropicalis):** Voriconazole has excellent activity against most Candida species, including those resistant to fluconazole (like *C. krusei* and some strains of *C. glabrata*). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits 14-alpha-demethylase, preventing the synthesis of ergosterol. * **Side Effects (High Yield):** 1. **Visual disturbances:** Photopsia (flashing lights) or blurred vision (transient). 2. **Skin:** Photosensitivity and increased risk of squamous cell carcinoma. 3. **Neurological:** Hallucinations. * **Metabolism:** Exhibits non-linear kinetics (saturation kinetics). * **Spectrum Tip:** Remember that among azoles, only **Posaconazole** and **Isavuconazole** cover Mucorales.

Q: Which of the following drugs is most likely to cause additive anemia and neutropenia if administered to an AIDS patient taking zidovudine?

Ganciclovir. **Explanation:** The correct answer is **Ganciclovir**. **1. Why Ganciclovir is correct:** The primary dose-limiting toxicity of **Zidovudine (AZT)**, a Nucleoside Reverse Transcriptase Inhibitor (NRTI), is **bone marrow suppression**, leading to macrocytic anemia and neutropenia. **Ganciclovir**, used for CMV retinitis in AIDS patients, also causes significant myelosuppression (specifically neutropenia). When administered together, they exert a **synergistic/additive toxic effect** on the bone marrow, severely increasing the risk of life-threatening cytopenias. **2. Analysis of Incorrect Options:** * **Acyclovir:** While used for HSV/VZV in AIDS patients, it is primarily nephrotoxic (obstructive uropathy) rather than myelosuppressive. It does not significantly potentiate Zidovudine’s hematologic toxicity. * **Amantadine:** This is an anti-influenza A and anti-Parkinsonian drug. Its side effects are mainly CNS-related (insomnia, dizziness, *Livedo reticularis*) and it does not cause bone marrow suppression. * **Stavudine (d4T):** Although it is an NRTI like Zidovudine, the combination is avoided because they are **antagonistic**. Both require phosphorylation by the same enzyme (thymidine kinase); Zidovudine inhibits the phosphorylation of Stavudine, reducing its efficacy. Their major shared toxicity is peripheral neuropathy/lactic acidosis, not additive anemia. **Clinical Pearls for NEET-PG:** * **Zidovudine (AZT):** High-yield side effects include bone marrow suppression and nail hyperpigmentation. It is the drug of choice for preventing vertical transmission of HIV. * **Ganciclovir:** Most common side effect is neutropenia. If neutropenia becomes severe, **G-CSF (Filgrastim)** can be used. * **Other Myelosuppressive Drugs in AIDS:** Be cautious when combining Zidovudine with **Flucytosine, Sulfonamides (TMP-SMX), or Interferon-alpha**, as these also suppress the marrow.

Q: Which antimicrobial agent inhibits ergosterol biosynthesis?

Ketoconazole. **Explanation:** The correct answer is **Ketoconazole**. To understand this, one must distinguish between drugs that inhibit the **synthesis** of ergosterol and those that bind to existing ergosterol. **1. Why Ketoconazole is correct:** Ketoconazole belongs to the **Azole** group of antifungals. Its primary mechanism of action is the inhibition of the enzyme **14-̑-demethylase** (a cytochrome P450 enzyme) [1]. This enzyme is responsible for converting lanosterol into ergosterol. By blocking this pathway, the fungal cell membrane becomes leaky and dysfunctional, leading to fungistatic effects [1]. **2. Why the other options are incorrect:** * **Amphotericin B:** This is a polyene antibiotic. It does not inhibit synthesis; instead, it **binds directly to ergosterol** already present in the fungal cell membrane, creating pores that cause leakage of intracellular ions (like $K^+$), leading to cell death [2], [3]. * **5-Flucytosine:** This is an antimetabolite. It is converted into 5-fluorouracil (5-FU) inside the fungal cell, which **inhibits DNA and RNA synthesis** [2], [4]. * **Griseofulvin:** This drug interferes with **mitotic spindle formation** by binding to polymerized microtubules, thereby inhibiting fungal mitosis. **Clinical Pearls for NEET-PG:** * **Squalene Epoxidase Inhibitors:** Terbinafine also inhibits ergosterol biosynthesis but at an earlier step (conversion of squalene to squalene epoxide). * **Echinocandins (e.g., Caspofungin):** These inhibit the synthesis of **̒-(1,3)-D-glucan**, a component of the fungal cell wall (not the membrane) [5]. * **Ketoconazole Side Effects:** It is notorious for inhibiting human steroid synthesis, leading to **gynecomastia** and decreased libido in males.

Q: Which antimicrobial agent inhibits ergosterol biosynthesis?

Ketoconazole. ### Explanation **Correct Answer: A. Ketoconazole** **Mechanism of Action:** Ketoconazole belongs to the **Azole** class of antifungals. These agents work by inhibiting the fungal cytochrome P450 enzyme **14α-demethylase**. This enzyme is responsible for converting lanosterol into **ergosterol**, an essential component of the fungal cell membrane. Inhibition leads to the depletion of ergosterol and the accumulation of toxic methylated sterols, resulting in increased membrane permeability and fungal cell death. **Analysis of Incorrect Options:** * **B. Amphotericin B:** This is a polyene antibiotic. It does not inhibit the *synthesis* of ergosterol; instead, it **binds directly to pre-formed ergosterol** in the fungal cell membrane, creating pores that cause leakage of intracellular ions (like $K^+$). * **C. 5-Flucytosine:** This is an antimetabolite. It is converted into 5-fluorouracil (5-FU) inside the fungal cell, which **inhibits DNA and protein synthesis** by interfering with thymidylate synthase. * **D. Griseofulvin:** This agent **interferes with microtubule function**, thereby inhibiting mitosis (spindle formation) in dermatophytes. **High-Yield Clinical Pearls for NEET-PG:** * **Ketoconazole Side Effects:** It is a potent inhibitor of human CYP450 enzymes and steroidogenesis, leading to side effects like **gynecomastia**, loss of libido, and menstrual irregularities. * **Drug of Choice (DOC):** While Ketoconazole was the first oral azole, it has largely been replaced by **Itraconazole** (DOC for Sporotrichosis and Histoplasmosis) and **Fluconazole** (DOC for Candidiasis and Cryptococcal meningitis) due to better safety profiles. * **Terbinafine:** Another ergosterol synthesis inhibitor, but it acts earlier in the pathway by inhibiting **Squalene epoxidase**.

Q: Mebendazole is used in the treatment of all EXCEPT:

Borrelia recurrentis. **Explanation:** The question asks for the exception regarding the clinical use of **Mebendazole**. However, there is a significant discrepancy in the provided options: Mebendazole is an **Anthelmintic** agent, while the options listed are bacteria and protozoa. In the context of the provided answer key, **Borrelia recurrentis** is the correct "exception" because it is a spirochete treated with Tetracyclines or Penicillin. However, it is crucial to note that Mebendazole is primarily used for **helminthic infections** (Nematodes like Ascaris, Hookworm, and Enterobius) by inhibiting microtubule synthesis [1], [3]. **Analysis of Options:** * **Borrelia recurrentis (Correct):** This is the causative agent of Relapsing Fever. It is a spirochete and is never treated with Mebendazole. The drug of choice is **Tetracycline** or **Erythromycin**. * **Giardia lamblia:** While Metronidazole is the drug of choice, Mebendazole and Albendazole have shown efficacy against Giardia by disrupting its cytoskeleton. * **Treponema vincenti & Gardnerella:** These are typically associated with anaerobic environments (e.g., Vincent’s angina or Bacterial Vaginosis). While Mebendazole is not a standard treatment, it belongs to the benzimidazole class, which shares structural similarities with **Nitroimidazoles** (like Metronidazole), leading to occasional cross-discussions in older pharmacological literature regarding anaerobic activity. **Clinical Pearls for NEET-PG:** 1. **Mechanism of Action:** Mebendazole binds to **̢-tubulin**, inhibiting microtubule polymerization in helminths [3]. 2. **Spectrum:** It is highly effective against "Pinworm, Whipworm, Roundworm, and Hookworm" [1]. 3. **Pharmacokinetics:** It has poor systemic absorption, making it ideal for luminal (gut) parasites but less effective for systemic tissues compared to Albendazole [3]. 4. **Teratogenicity:** Benzimidazoles are generally avoided in the first trimester of pregnancy [2].

Q: What is the drug of choice for treating cholera in pregnant women?

None of the above. The correct answer is **None of the above** because the current drug of choice (DOC) for cholera in pregnant women is **Azithromycin**. ### 1. Why "None of the above" is correct According to the WHO and current clinical guidelines, **Azithromycin** (a macrolide) is the preferred treatment for cholera in pregnant women and children. It is highly effective against *Vibrio cholerae*, achieves high concentrations in the intestinal lumen, and has a superior safety profile during pregnancy (FDA Category B). It is typically administered as a single 1g oral dose. ### 2. Why the other options are incorrect * **Tetracycline & Doxycycline (Options A & B):** While Doxycycline is the DOC for non-pregnant adults, tetracyclines are **contraindicated** in pregnancy. They cross the placenta and can cause permanent teeth discoloration (yellow-brown) and enamel hypoplasia in the fetus, as well as inhibit bone growth [1]. * **Furazolidone (Option C):** Historically, Furazolidone was used for cholera in pregnancy; however, it is no longer the first-line choice due to lower efficacy compared to macrolides and the availability of safer, more effective alternatives like Azithromycin. ### 3. Clinical Pearls for NEET-PG * **Primary Treatment:** The most critical intervention in cholera is **aggressive fluid resuscitation** (ORS or IV Ringer’s Lactate); antibiotics only shorten the duration of diarrhea and shedding. * **DOC Summary:** * **Adults (Non-pregnant):** Doxycycline (Single dose 300mg). * **Pregnant Women:** Azithromycin. * **Children:** Azithromycin is preferred (Zinc supplementation is also vital in pediatric cases). * **Resistance Note:** In areas with known macrolide resistance, **Ceftriaxone** may be considered as an alternative.

Question 1

Maraviroc acts as which of the following?

Accepted Answer

Entry inhibitor

Answer

Reverse transcriptase inhibitor

Answer

Protease inhibitor

Answer

None of the above

Question 2

What is the difference in the action of Diethylcarbamazine (DEC) and Ivermectin in scrotal filariasis?

Accepted Answer

DEC acts on adult worms, while Ivermectin acts on microfilariae.

Answer

DEC is more effective on microfilariae than Ivermectin.

Answer

DEC acts only on microfilariae, while Ivermectin acts only on adult worms.

Answer

DEC acts on both microfilariae and adult worms, while Ivermectin acts on adult worms only.

Question 3

Which of the following drugs is not used for the treatment of typhoid?

Accepted Answer

Cefixime

Answer

Chloramphenicol

Answer

Ciprofloxacin

Answer

Ceftriaxone

Question 4

Voriconazole is not effective against which of the following?

Accepted Answer

Mucormycosis

Answer

Aspergillosis

Answer

Candida albicans

Answer

Candida tropicalis

Question 5

A 10-year-old boy presents with acute bloody diarrhea and fever. What is the drug of choice for suspected Shigella infection?

Accepted Answer

Ciprofloxacin

Answer

Penicillin

Answer

Doxycycline

Answer

Azithromycin

Question 6

Which of the following drugs is most likely to cause additive anemia and neutropenia if administered to an AIDS patient taking zidovudine?

Accepted Answer

Ganciclovir

Answer

Acyclovir

Answer

Amantadine

Answer

Stavudine

Question 7

Which antimicrobial agent inhibits ergosterol biosynthesis?

Accepted Answer

Ketoconazole

Answer

Amphotericin B

Answer

5-flucytosine

Answer

Griseofulvin

Question 8

Which antimicrobial agent inhibits ergosterol biosynthesis?

Accepted Answer

Ketoconazole

Answer

Amphotericin B

Answer

5-flucytosine

Answer

Griseofulvin

Question 9

Mebendazole is used in the treatment of all EXCEPT:

Accepted Answer

Borrelia recurrentis

Answer

Giardia lamblia

Answer

Treponema vincenti

Answer

Gardnerella infections

Question 10

What is the drug of choice for treating cholera in pregnant women?

Accepted Answer

None of the above

Answer

Tetracycline

Answer

Doxycycline

Answer

Furazolidone

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?